eISSN: 2354-0265
ISSN: 2353-6942
Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO
Current issue Archive Online first About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
3/2018
vol. 12
 
Share:
Share:
abstract:
Original paper

Effectiveness of hemoperfusion in treatment of patients with non-biliary moderately severe pancreatitis

Oleksandr Oliynyk
,
Anna Ślifirczyk
,
Bogdana Pereviznyk
,
Wiktor Kushnarov

Health Prob Civil. 2018; 12(3): 204-208
Online publish date: 2018/07/12
View full text Get citation
 
PlumX metrics:
Background
Acute pancreatitis morbidity has been rising annually all around the world. In case of acute necrotic pancreatitis, the mortality reaches 40% in the majority of hospitals. The therapy is effective if the efferent methods involve complex therapy of this disease. One such method is hemoperfusion, i.e. extracorporeal blood purification, which is widely used in toxicology. The authors of the article used hemoperfusion in a complex therapy in patients with severe acute pancreatitis. The following research presents an evaluation of the results of hemoperfusion used in a complex therapy of patients with acute pancreatitis.

Material and methods
The study involved 38 patients with acute non-biliary moderately severe pancreatitis who were treated at an intensive care unit of Ternopil University Hospital in Ukraine. 18 patients were treated following the protocol for treatment of acute pancreatitis. In 20 patients, this treatment was additionally combined with hemoperfusion. We determined the levels of amylase, diastase, procalcitonin, bilirubin, malonic dialdehyde, and diene conjugates in blood serum and the level of leukocytes in the blood.

Results
The levels of procalcitonin, amylase, bilirubin, leukocytes number, malonic dialdehyde, and diene conjugates were stabilised in patients of both groups, but in those who received hemoperfusion demonstrated much better results. These were manifested by significantly better levels of the amylase, bilirubin, creatinine, urea, procalcitonin, malonic dialdehyde, and diene conjugates in patients who received hemoperfusion (p< 0,005) than in the other group undergoing standard drug therapy.

Conclusions
Hemoperfusion can be used as an effective method in the complex treatment of patients with acute pancreatitis.

keywords:

acute pancreatitis, hemoperfusion, amylase, procalcitonin


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.